MedMen Enterprises Inc.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MedMen Enterprises, Inc. engages in the manufacture and marketing of cannabis products. It operates through the following geographical segments: California, Illinois, Nevada, Arizona, and Massachusetts. The company was founded by Adam Bierman and Andrew Modlin on May 21, 1987 and is headquartered in Boca Raton, FL.

Aurora Cannabis

Canopy Growth

The grass will not be greener with these cannabis stocks.

3 Marijuana Stocks to Avoid Like the Plague in 2020

MedMen Enterprises is continuing to slim down following an acquisition binge and industry downturn that left the cannabis retailer's finances in the red.

Cannabis industry growing pains lead MedMen to ditch Arizona

Green Thumb Industries Inc.

GW Pharmaceuticals

Though it was a poor year for pot stocks, plenty of cannabis history was still made.

The 5 Biggest Marijuana Milestones in 2019

MedMen Enterprises Inc. shares MMNFF, -6.74% MMEN, -5.80% slid more than 6% Friday, after the company said it has executed the term sheet for a dilutive equity financing of $20 million as part of a fundraising totaling $74 million.

MedMen shares slide 7% after cannabis retailer preps dilutive equity financing

Cannabis retailer MedMen Enterprises Inc. MMNFF, -0.66% MMEN, -9.21% said Friday it expects to raise $74 million through the sale of licenses in states viewed as non-core and an offering of class B subordinate voting shares.

MedMen to raise $74 million through the sale of licenses in non-core states, class B stock offering

Cronos Group

OrganiGram Holdings Inc.

Tilray Brands

Cannabis stocks rallied out of the gate Friday, after a report that the Canadian province of Ontario will open up the market for retailers with plans to issue abut 20 new store approvals starting in April of 2020. The news reported by Canadian network CBC eased concerns about the shortage of stores that has hampered the development of the legal cannabis market in Canada and allowed the black market to continue to thrive.

Cannabis stocks rally out of the gate on report Ontario to open market for store openings

U.S. marijuana retail company MedMen Enterprises Inc. MMNFF, +14.44% is laying off more workers and transferring voting rights away from a co-founder as it continues to fight off a cash crunch.

Pot retailer MedMen increases layoffs, president gives up voting rights

Innovative Industrial Properties

Trulieve Cannabis Corp.

The days of smooth sailing for cannabis stocks have come to an abrupt end.

3 Things We Learned About Marijuana Stocks in 2019

These cannabis stocks are liable to be buzzkill for years to come.

3 Marijuana Stocks to Sell Before 2020

HEXO Corp

Wall Street's consensus earnings-per-share projections for pot stocks keeps falling.

Surprise! Marijuana Stock Losses May Continue Through 2021

Marijuana stocks are getting creative in order to cut costs and bolster their cash on hand.

Cannabis Stocks Are Scrambling to Conserve Cash

MedMen Enterprises Inc (OTC: MMNFF) (CSE: MMEN) reported first-quarter results Wednesday as the cannabis company embarks on cost-cutting efforts that include 190 layoffs.

MedMen Reports Q1 Results In Wake Of Restructuring Announcement

Medmen Enterprises Inc (MMNFF) CEO Adam Bierman on Q1 2020 Results - Earnings Call Transcript

MedMen Enterprises Inc. MMNFF, -3.74% MMEN, -4.48% reported Tuesday that revenue rose 105% but the cannabis company missed Wall Street consensus sales estimates.

MedMen revenue rises 105% but misses estimates

The state is a big one for the industry and crucial to its long-term success.

Why Did California Suspend Over 400 Cannabis Businesses, and What Does That Mean for the Industry?

Could this tarnished pot stock possibly stage a turnaround? Most don't think so.

Is MedMen Enterprises Stock a Buy?

Shares of MedMen Enterprises Inc. MMNFF, -20.05% tumbled 21% toward a record low in active afternoon trading Monday, in the wake of the California-based cannabis retailer's announcement of job cuts and plans to sell assets in an effort to cut spending.

MedMen's stock extends selloff below a buck after job cuts, plans for asset sales

Cannabis retailer MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) announced Friday a strategic plan to reach its target of positive EBITDA by the end of 2020 that includes the layoff of 190 employees.

MedMen To Lay Off More Than 190 Employees, Announces Plan To Achieve Positive EBITDA

Curaleaf Holdings, Inc.

Once blazing hot, the appetite for cannabis mergers and acquisitions has cooled considerably in the United States.

Marijuana M&A Deals Are a Mess in the U.S.

MedMen Enterprises Inc. MMNFF, -3.43% MMEN, -2.99% , a U.S. marijuana retail chain, announced Friday afternoon that it is cutting more than 20% of its staff and looking to sell some of its assets amid a cash crunch.

U.S. marijuana retailer MedMen to slash staff, sell off assets

These billion-dollar markets are making it impossible for their cannabis industries to thrive.

These 2 States Are Sabotaging Their Respective Marijuana Industries

Aphria

Paper losses are piling up for pot stock investors.

Marijuana Stocks Have Lost (at Least) $35 Billion in Market Value Since April

MedMen: A Pot-Stock Stinker For The Long Haul

SNDL Inc.

Are these pot stocks really cheap, or complete value traps?

3 Cannabis Stocks Valued at Less Than 1 Times Next Year's Sales -- What Gives?

The grass may not be greener for these widely held marijuana stocks.

News for MedMen Enterprises Inc. Stock (MMNFF)